Abita JP - Search Results

1

Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells.

Giacchetti S, Gauvillé C, de Crémoux P, Bertin L, Berthon P, Abita JP, Cuttitta F, Calvo F. Giacchetti S, et al. Among authors: abita jp. Int J Cancer. 1990 Aug 15;46(2):293-8. doi: 10.1002/ijc.2910460226. Int J Cancer. 1990. PMID: 2166713

2

Gs alpha availability to cholera toxin-catalysed ADP-ribosylation is decreased in membranes of retinoic acid-treated leukemic cell lines HL-60 and THP-1. A posttranslational effect.

de Cremoux P, Zimber A, Calvo F, Lanotte M, Mercken L, Abita JP. de Cremoux P, et al. Among authors: abita jp. Biochem Pharmacol. 1991 Nov 6;42(11):2141-6. doi: 10.1016/0006-2952(91)90349-a. Biochem Pharmacol. 1991. PMID: 1659820

3

1,25 Dihydroxyvitamin D3 modulates adenylate cyclase activity of the human breast cancer cell line T47D through increased synthesis of Gs.

de Cremoux P, Calvo F, Lagier G, Lachat P, Abita JP, Maus M, Premont J. de Cremoux P, et al. Among authors: abita jp. Biochem Pharmacol. 1989 Sep 15;38(18):3111-4. doi: 10.1016/0006-2952(89)90022-1. Biochem Pharmacol. 1989. PMID: 2506866 No abstract available.

4

1,25-Dihydroxycholecalciferol induces an increase in PGE1- and forskolin-stimulated cyclic-AMP production in T47D human breast cancer cell line.

de Cremoux P, Calvo F, Cost H, Gauville C, Lagier G, Abita JP, Lechat P. de Cremoux P, et al. Among authors: abita jp. Fundam Clin Pharmacol. 1987;1(5):347-55. doi: 10.1111/j.1472-8206.1987.tb00572.x. Fundam Clin Pharmacol. 1987. PMID: 2832283

5

Quantitative modifications of major histocompatibility complex (MHC) antigens induced by recombinant gamma interferon in two human breast cancer lines.

Calvo F, Jabrane N, Faille A, Gauville C, de Cremoux P, Lagier G, Abita JP, Lechat P. Calvo F, et al. Among authors: abita jp. Int J Immunopharmacol. 1987;9(4):459-68. doi: 10.1016/0192-0561(87)90020-8. Int J Immunopharmacol. 1987. PMID: 3114155

6

Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugs.

Chomienne C, Chedeville A, Balitrand N, De Cremoux P, Abita JP, Degos L. Chomienne C, et al. Among authors: abita jp. In Vivo. 1988 May-Aug;2(3-4):281-8. In Vivo. 1988. PMID: 2979844

7

Characterization of insulin receptors in human promyelocytic leukemia cell HL60.

Abita JP, Gauville C, Saal F. Abita JP, et al. Biochem Biophys Res Commun. 1982 May 31;106(2):574-81. doi: 10.1016/0006-291x(82)91149-4. Biochem Biophys Res Commun. 1982. PMID: 7049178 No abstract available.

8

Binding of 125I-insulin to the human histiocytic lymphoma cell line U-937: effect of differentiation with retinoic acid.

Abita JP, Gauville C, Balitrand N, Gespach C, Canivet J. Abita JP, et al. Leuk Res. 1984;8(2):213-21. doi: 10.1016/0145-2126(84)90145-0. Leuk Res. 1984. PMID: 6143861

9

In vitro effects of retinoic acid.

Chomienne C, Ballerini P, Huang M, Cornic M, Abita JP, Castaigne S, Degos L. Chomienne C, et al. Among authors: abita jp. Nouv Rev Fr Hematol (1978). 1990;32(1):32-4. Nouv Rev Fr Hematol (1978). 1990. PMID: 2190177 Review.

10

The differentiating agent, retinoic acid, causes an early inhibition of inositol lipid-specific phospholipase C activity in HL-60 cells.

Geny B, Cost H, Barreau P, Basset M, Le Peuch C, Abita JP, Cockcroft S. Geny B, et al. Among authors: abita jp. Cell Signal. 1991;3(1):11-23. doi: 10.1016/0898-6568(91)90003-d. Cell Signal. 1991. PMID: 1903636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters